‘Weight’ & Watch: Indian Pharma Set To Enter Ozempic, Wegovy Market, But Swift Price Crash Unlikely

The Indian market for GLP-1 drugs has not fully opened yet, mainly due to the unavailability of these leading brands and affordability issues. But even if Ozempic and other popular versions were available in India, they would have remained out of reach for many due to their high cost